Sanbin Wang
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
Papers in
- Oncology 18
- CAR-T cell therapy research 12
- Hematology 16
- Hematopoietic Stem Cell Transplantation 12
- Chronic Myeloid Leukemia Treatments 4
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Lei Gao (13 shared papers)Yao Liu (10 shared papers)Li Gao (9 shared papers)Xi Zhang (12 shared papers)Peiyan Kong (7 shared papers)Yi Su (4 shared papers)Cheng Zhang (6 shared papers)Tonghua Yang (3 shared papers)
- Journals
- Blood (4 papers)Cancer Research (2 papers)Frontiers in Immunology (2 papers)Haematologica (2 papers)International Journal of Hematology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Sanbin Wang
26 papers receiving 257 citations
Sanbin Wang's Hit Papers
Peers
Comparison fields: 5 of 50
- Hematology 102
- Oncology 137
- Genetics 49
- Immunology 52
- Public Health, Environmental and Occupational Health 39
Countries citing papers authored by Sanbin Wang
This map shows the geographic impact of Sanbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanbin Wang more than expected).
Fields of papers citing papers by Sanbin Wang
This network shows the impact of papers produced by Sanbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanbin Wang. The network helps show where Sanbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Sanbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 43 | |
| 2 | 2015 | 42 | |
| 3 | Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial Hit paper breakdown → | 2024 | 41 |
| 4 | 2018 | 18 | |
| 5 | 2023 | 17 | |
| 6 | 2019 | 13 | |
| 7 | 2013 | 11 | |
| 8 | 2019 | 10 | |
| 9 | 2020 | 9 | |
| 10 | 2012 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2020 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2024 | 3 | |
| 17 | [HLA haploidentical peripheral blood stem cells transplantation for β thalassemia major]. | 2011 | 3 |
| 18 | 2017 | 3 | |
| 19 | 2018 | 2 | |
| 20 | 2025 | 2 |
About Sanbin Wang
Sanbin Wang is a scholar working on Oncology, Hematology, Immunology, Genetics and Public Health, Environmental and Occupational Health, having authored 31 papers that have together received 259 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Hematopoietic Stem Cell Transplantation (12 papers), Acute Lymphoblastic Leukemia research (5 papers), Immune Cell Function and Interaction (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Nanowire Synthesis and Applications (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (102 citations), Oncology (137 citations), Genetics (49 citations), Immunology (52 citations) and Public Health, Environmental and Occupational Health (39 citations). Sanbin Wang has collaborated with scholars based in China and United States. Frequent co-authors include Lei Gao, Yao Liu, Li Gao, Xi Zhang, Peiyan Kong, Yi Su, Cheng Zhang, Tonghua Yang, Jishi Wang and Jia Liu. Their work appears in journals such as Blood, Cancer Research, Frontiers in Immunology, Haematologica and International Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.